4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001209191-21-008521
Options or other derivatives
- Chief Financial Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Quinn William P. Chief Financial Officer | 2021-02-04 | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…